Date: Thursday, November 4, 2010 - Sunday, November 7 2010
Clinical Trials Project LEAD is a four-day advanced course open to graduates of Project LEAD courses prior to 2007 and the Project LEAD Institute after 2007. The course focuses on understanding and improving breast cancer clinical trials research. This course is part of NBCC’s Clinical Trials Initiative and trains advocates to participate in all levels of the clinical trials process from evaluating trial design to serving on Institutional Review Boards and Data Safety Monitoring Boards. This advanced course is offered every other year-apply now to avoid missing this wonderful course!
• Learn about the purpose, design, and endpoints associated with different phases and types of clinical trials;
• Explore the similarities and differences in clinical trials in the metastatic, adjuvant, and preventive settings;
• Acquire the skills to critically evaluate research protocols;
• Understand ethical issues in clinical trials such as autonomy, beneficence, and justice;
• Become familiar with the drug development process, and key terms such as accelerated approval and surrogate endpoints;
• Discuss the intersection of current trends in clinical trials public policy and methodology with advocacy.
Clinical Trials Project LEAD graduates will represent NBCC in research partnerships, at scientific conferences, on key committees, and in other research settings.
Application for Clinical Trials Project LEAD is a three step process:
Step 1: Submit the online application or the application with scholarship if you are in need. Only one application is required so please submit the application that applies to your situation. It will either be:
a. Clinical Trials Application or
b. Clinical Trials Application with Scholarship Application
Step 2: Access and download the four essay questions. Please be sure to include your name and email address where indicated. Answers should be approximately one page in length per question.
Step 3: Access and download the templates for your letters of reference. Applicants are required to submit at least two letters for a completed application. Letters from the NBCC advocacy community and leadership as well as letters from colleagues in the clinical trials and research communities who know your work are highly preferred.
Your completed application must be received by NBCC by the September 22nd deadline.
If you have any questions or require assistance, please contact us at email@example.com